Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer

Cell Death & Differentiation, Published online: 10 May 2022; doi:10.1038/s41418-022-01012-0Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer

Source: Cell Death and Differentiation - May 10, 2022 Category: Cytology Authors: Jinrui Zhang Ge Zhang Wenjing Zhang Lu Bai Luning Wang Tiantian Li Li Yan Yang Xu Dan Chen Wenting Gao Chuanzhou Gao Chaoqun Chen Menglin Ren Yuexia Jiao Hongqiang Qin Yu Sun Lili Zhi Yangfan Qi Jinyao Zhao Quentin Liu Han Liu Yang Wang Source Type: research